US Patent Issued to Chengdu Shibeikang Biomedical Technology on July 29 for "Crystalline form B of tetrahydrothienopyridine compound, preparation method, composition and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,439, issued on July 29, was assigned to Chengdu Shibeikang Biomedical Technology Co. Ltd. (Sichuan, China).

"Crystalline form B of tetrahydrothienopyridine compound, preparation method, composition and application thereof" was invented by Guodong Cen (Sichuan, China), Maoting Yang (Sichuan, China) and Shaojun Tan (Sichuan, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed in the present invention are a crystalline form B of a tetrahydrothienopyridine compound having a structure as represented by Compound I, a preparation method, a composition and an application thereof, for use in solving the problems in the prior art of lots of impurit...